Concepedia

Thilini Hemali Senevirathne

TH

Statistics

Publications

3

Citations

69

H-Index

3

Active since

2023

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Broad Institute

Amsterdam University Medical Centers

KU Leuven

Thilini Hemali Senevirathne is an author at Harvard University specializing in covid-19, medicine, and covid-19 epidemiology.

ORCID

Top concepts

Publications per year

2023–2024

3

Publications

3

COVID-19: From emerging variants to vaccination

Thilini Hemali Senevirathne, Demi Wekking, Joseph W. R. Swain et al. · Cytokine & Growth Factor Reviews · 2023 · 33 citations

, , +3

Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer

Mercedes Marín‐Aguilera, Pedro Jares, Esther Sanfeliu et al. · ESMO Open · 2024 · 24 citations · Full text

The impact of COVID-19 on cancer patients

Demi Wekking, Thilini Hemali Senevirathne, Josie Pearce et al. · Cytokine & Growth Factor Reviews · 2023 · 12 citations · Full text

, , +6

Rows per page

1–3 of 3